Although E2 exhibited an exclusive up-regulation of target genes through direct activation of ERα, the GPR30–EGFR transduction pathway was involved in estrogen-induced proliferation of ovarian tumor cells, as evidenced by silencing GPR30 and using specific pharmacologic inhibitors. Here, EGFR is linked to ovarian neoplasm.